Parameters | N | % |
---|---|---|
Age | ||
Median (range) | 56 (30–90) | |
Status | ||
Died | 457 | 52.20% |
Censored | 161 | 18.40% |
Alive | 257 | 29.40% |
Menopause | ||
No | 273 | 31.20% |
Yes | 602 | 68.80% |
FIGO stage | ||
Early (FIGO I, II) | 75 | 8.60% |
Late (FIGO III, IV) | 800 | 91.40% |
Family history | ||
No | 643 | 73.70% |
Yes | 230 | 26.30% |
BMI | ||
Median (range) | 22.8 (15.6–37.3) | |
Underweight (< 18.5) | 49 | 5.70% |
Normal (18.5–23.9) | 597 | 69.70% |
Overweight (24–27.9) | 184 | 21.50% |
Obese (≥ 28) | 26 | 3.00% |
PNI | ||
Median (range) | 46.2 (29.2–67.7) | |
< 45.45 | 394 | 45.50% |
≥ 45.45 | 472 | 54.50% |
CA125 | ||
<500 | 193 | 22.60% |
≥ 500 | 662 | 77.40% |
Ascites | ||
No | 99 | 11.30% |
<500 ml | 146 | 16.70% |
≥ 500 ml | 629 | 72.00% |
Residual disease | ||
No | 272 | 31.10% |
Yes | 603 | 68.90% |
Platinum sensitivity | ||
NA | 44 | 5.20% |
Yes | 568 | 66.90% |
No | 237 | 27.90% |